Patents by Inventor Erik Wallen

Erik Wallen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
    Patent number: 7173024
    Abstract: Compounds of the formula (I), wherein the symbol aa means a residue of an ?-amino acid. The invention is also directed to a method for the preparation of the compounds of formula (I), as well as their use as prolyl oligopeptide inhibitors, for example for the treatment of Alzheimer's disease.
    Type: Grant
    Filed: July 4, 2002
    Date of Patent: February 6, 2007
    Assignee: Orion Corporation
    Inventors: Jukka Gynther, Pekka Männistö, Erik Wallen, Johannes Christiaans, Markus Forsberg, Antti Poso, Jarkko Venäläinen, Elina Jarho
  • Compounds having prolyl oligopeptidase inhibitory activity
    Publication number: 20060229254
    Abstract: A compound of formula (I), wherein X, R1, R2 and R3 are as defined in the disclosure, or a pharmaceutically acceptable salt or ester thereof, useful as a prolyl oligopeptidase inhibitor. The compounds can be used for the treatment of diseases or conditions where prolyl oligopeptidase inhibitors are indicated to be effective, for example for the treatment of neurodegenerative diseases, such as Alzheimer's disease and senile dementia.
    Type: Application
    Filed: January 2, 2004
    Publication date: October 12, 2006
    Inventors: Jukka Gynther, Erik Wallen, Elina Jarho, Pekka Mannisto, Markus Forsberg, Antti Poso, Johannes Christiaans, Jarkko Venalainen, Jouko Vepsalainen, Taija Saarinen, Tomi Jarvinen
  • Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use
    Publication number: 20050020677
    Abstract: Compounds of the formula (I), wherein the symbol aa means a residue of an ?-amino acid. The invention is also directed to a method for the preparation of the compounds of formula (I), as well as their use as prolyl oligopeptide inhibitors, for example for the treatment of Alzheimer's disease.
    Type: Application
    Filed: July 4, 2002
    Publication date: January 27, 2005
    Inventors: Jukka Gynther, Pekka Mannisto, Erik Wallen, Johannes Christiaans, Markus Forsberg, Antti Poso, Jarkko Venalainen, Elina Jarho
  • Methods for using heat shock proteins
    Patent number: 6455493
    Abstract: The present invention provides a heat shock protein immunotoxin comprising: at least a fragment of a heat shock protein, the fragment being capable of being bound by an immune cell; and a toxin bound to the fragment. The present invention also provides a method for decreasing the number of immune cells in an individual using the heat shock protein immunotoxins of the present invention. In addition, the present invention provides a method for decreasing the number of immune cells in an organ using the heat shock protein immunotoxins of the present invention.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: September 24, 2002
    Assignee: University of New Mexico
    Inventors: Erik Wallen, Pope L. Moseley